blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1854793

EP1854793 - NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  04.07.2014
Database last updated on 30.09.2024
Most recent event   Tooltip04.07.2014Application deemed to be withdrawnpublished on 06.08.2014  [2014/32]
Applicant(s)For all designated states
Japan Tobacco, Inc.
2-1, Toranomon 2-chome, Minato-ku
Tokyo 105-8422 / JP
[2007/46]
Inventor(s)01 / KODAMA, Yoshitoshi
Central Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho
Takatsuki-shi, Osaka 5691125 / JP
02 / NOJI, Satoru
Central Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho
Takatsuki-shi, Osaka 5691125 / JP
03 / IMAMURA, Katsuaki
Central Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho
Takatsuki-shi, Osaka 5691125 / JP
04 / MIZOJIRI, Ryo
Higashiota 3-5-B-1005
Ibaraki, Osaka 567-0012 / JP
05 / AOKI, Kenta
Central Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho
Takatsuki-shi, Osaka 5691125 / JP
06 / TAKAGI, Hideo
Central Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho
Takatsuki-shi, Osaka 5691125 / JP
07 / NAKA, Yuichi
ICentral Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho
Takatsuki-shi, Osaka 5691125 / JP
08 / ITO, Goro
Toxicology Research Laboratories
23 Naganuki
Hadano-shi, Kanagawa 2570024 / JP
09 / SHINODA, Kiyotaka
Central Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho
Takatsuki-shi, Osaka 5691125 / JP
10 / FUJIWARA, Akihito
Central Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho
Takatsuki-shi, Osaka 5691125 / JP
11 / KURIHARA, Kazunori
RAIFUSUTEIJT KITAOODOORI B-305
Kita 22 Nishi 5-1-28
Kita-ku, Sapporo 001-0022 / JP
12 / TANAKA, Masaru
Central Pharmaceutical Research
Institute of Japan Tobacco Inc.
1-1, Murasaki-cho
Takatsuki-shi, Osaka 5691125 / JP
 [2013/40]
Former [2008/02]01 / KODAMA, Yoshitoshi c/o Central Pharmaceutical
Research Institute of Japan Tobacco Inc., 1-1
Murasa ki-cho, Takatsuki-shi, Osaka 5691125 / JP
02 / NOJI, Satoru c/o Central Pharmaceutical Research
Institute of Japan Tobacco Inc., 1-1, Murasaki
cho, Takatsuki-shi, Osaka, 5691125 / JP
03 / IMAMURA, Katsuaki c/o Central Pharmaceutical
Research Institute of Japan Tobacco Inc., 1-1
Murasak i-cho, Takatsuki-shi, Osaka, 5691125 / JP
04 / MIZOJIRI, Ryo
Higashiota 3-5-B-1005
Ibaraki, Osaka 567-0012 / JP
05 / AOKI, Kenta c/o Central Pharmaceutical Research
Institute of Japan Tobacco Inc., 1-1, Murasaki
cho, Takatsuki-shi, Osaka, 5691125 / JP
06 / TAKAGI, Hideo c/o Central Pharmaceutical
Research Institute of Japan Tobacco Inc., 1-1
Murasaki-ch o, Takatsuki-shi, Osaka, 5691125 / JP
07 / NAKA, Yuichi c/o Central Pharmaceutical Research
Institute of Japan Tobacco Inc., 1-1, Murasaki
cho, Takatsuki-shi, Osaka, 5691125 / JP
08 / ITO, Goro c/o Toxicology Research Laboratories
23 Naganuki, Hadano-shi, Kanagawa
2570024 / JP
09 / SHINODA, Kiyotaka c/o Central Pharmaceutical
Research Institute of Japan Tobacco Inc., 1-1
Murasak i-cho, Takatsuki-shi, Osaka, 5691125 / JP
10 / FUJIWARA, Akihito c/o Central Pharmaceutical
Research Institute of Japan Tobacco Inc., 1-1
Murasak i-cho, Takatsuki-shi, Osaka, 5691125 / JP
11 / KURIHARA, Kazunori
RAIFUSUTEIJT KITAOODOORI B-305
Kita 22 Nishi 5-1-28, Kita-ku, Sapporo 001-0022 / JP
12 / TANAKA, Masaru c/o Central Pharmaceutical Researc
Institute of Japan Tobacco Inc., 1-1
Murasaki-c ho, Takatsuki-shi, Osaka, 5691125 / JP
Former [2007/46]01 / KODAMA, Yoshitoshi c/o Central Pharmaceutical
Research Institute of Japan Tobacco Inc., 1-1
Murasa ki-cho, Takatsuki-shi, Osaka 5691125 / JP
02 / NOJI, Satoru c/o Central Pharmaceutical Research
Institute of Japan Tobacco Inc., 1-1, Murasaki
cho, Takatsuki-shi, Osaka, 5691125 / JP
03 / IMAMURA, Katsuaki c/o Central Pharmaceutical
Research Institute of Japan Tobacco Inc., 1-1
Murasak i-cho, Takatsuki-shi, Osaka, 5691125 / JP
04 / MIZOJIRI, Ryo c/o Central Pharmaceutical Research
Institute of Japan Tobacco Inc., 1-1, Murasaki
cho Takatsuki-shi, Osaka, 5691125 / JP
05 / AOKI, Kenta c/o Central Pharmaceutical Research
Institute of Japan Tobacco Inc., 1-1, Murasaki
cho, Takatsuki-shi, Osaka, 5691125 / JP
06 / TAKAGI, Hideo c/o Central Pharmaceutical
Research Institute of Japan Tobacco Inc., 1-1
Murasaki-ch o, Takatsuki-shi, Osaka, 5691125 / JP
07 / NAKA, Yuichi c/o Central Pharmaceutical Research
Institute of Japan Tobacco Inc., 1-1, Murasaki
cho, Takatsuki-shi, Osaka, 5691125 / JP
08 / ITO, Goro c/o Toxicology Research Laboratories
23 Naganuki, Hadano-shi, Kanagawa
2570024 / JP
09 / SHINODA, Kiyotaka c/o Central Pharmaceutical
Research Institute of Japan Tobacco Inc., 1-1
Murasak i-cho, Takatsuki-shi, Osaka, 5691125 / JP
10 / FUJIWARA, Akihito c/o Central Pharmaceutical
Research Institute of Japan Tobacco Inc., 1-1
Murasak i-cho, Takatsuki-shi, Osaka, 5691125 / JP
11 / KURIHARA, Kazunori c/o Central Pharmaceutical
Research Institute of Japan Tobacco Inc., 1-1
Murasa ki-cho, Takatsuki-shi, Osaka, 5691125 / JP
12 / TANAKA, Masaru c/o Central Pharmaceutical Researc
Institute of Japan Tobacco Inc., 1-1
Murasaki-c ho, Takatsuki-shi, Osaka, 5691125 / JP
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2007/46]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date06728596.524.02.2006
[2007/46]
WO2006JP304034
Priority number, dateJP2005005246928.02.2005         Original published format: JP 2005052469
US20050658885P04.03.2005         Original published format: US 658885 P
JP2006001175119.01.2006         Original published format: JP 2006011751
US20060763045P27.01.2006         Original published format: US 763045 P
[2007/46]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006093247
Date:08.09.2006
Language:JA
[2006/36]
Type: A1 Application with search report 
No.:EP1854793
Date:14.11.2007
Language:EN
[2007/46]
Search report(s)International search report - published on:JP08.09.2006
(Supplementary) European search report - dispatched on:EP29.12.2010
ClassificationIPC:C07D409/14, A61K31/4436, A61K31/4439, A61K31/444, A61K31/4545, A61K31/496, A61K31/506, A61K31/5377, A61K31/541, A61P11/06, A61P17/00, A61P19/02, A61P25/00, A61P27/02, A61P27/16, A61P29/00, A61P35/00, A61P35/02, A61P37/02
[2007/46]
CPC:
C07D409/14 (EP,KR); C07D417/14 (EP,KR,US); A61P11/06 (EP);
A61P17/00 (EP); A61P19/02 (EP); A61P25/00 (EP);
A61P27/02 (EP); A61P27/16 (EP); A61P29/00 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P37/02 (EP);
A61P37/08 (EP); A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/46]
Extension statesAL19.09.2007
BA19.09.2007
HR19.09.2007
MK19.09.2007
YU19.09.2007
TitleGerman:NEUE AMINOPYRIDINVERBINDUNG MIT SYK-HEMMENDER WIRKUNG[2007/46]
English:NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY[2007/46]
French:NOUVEAU COMPOSÉ AMINOPYRIDINE AYANT UNE ACTIVITÉ D'INHIBITION DE LA Syk[2007/46]
Entry into regional phase23.08.2007Translation filed 
19.09.2007National basic fee paid 
19.09.2007Search fee paid 
19.09.2007Designation fee(s) paid 
19.09.2007Examination fee paid 
Examination procedure19.09.2007Examination requested  [2007/46]
05.04.2011Amendment by applicant (claims and/or description)
02.09.2013Communication of intention to grant the patent
14.01.2014Application deemed to be withdrawn, date of legal effect  [2014/32]
19.02.2014Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2014/32]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.09.2013
Fees paidRenewal fee
28.02.2008Renewal fee patent year 03
27.02.2009Renewal fee patent year 04
23.02.2010Renewal fee patent year 05
21.02.2011Renewal fee patent year 06
23.02.2012Renewal fee patent year 07
25.02.2013Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
28.02.201409   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]WO2004087698  (VERTEX PHARMA [US], et al) [AD] 1-32* the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.